Dr. Alexander brings two decades of biotechnology, biopharma, and medical leadership, most recently as SVP, Research & Development and Head of Boston Roche Innovation Center (BRIC), for ...

The Hillsboro Herald regularly tracks the happenings at Hillsboro City Hall, at least to the best of our ability we ...

Nykode Therapeutics (VACBF) announced last night that it has received notification from Genentech, a member of the Roche (RHHBY), of its ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Revenue: Total revenue was $26.1 million for the third quarter of 2024, compared to $10.5 million for the third quarter of ...

Conjunctival breach and a late onset are common in cases of endophthalmitis associated with implantation of an anti-VEGF delivery device.

Genentech, a member of the Roche (RHHBY), announced that it will present more than 40 abstracts across nine blood disorders at the 66th ...

Genentech to Present New and Encouraging Long-term Follow-up Data Across Broad Hematology Portfolio at ASH 2024 ...

The United States is home to one of the leading healthcare systems globally, primarily due to its remarkable ability to drive ...

--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from the open-label, single-arm Phase IV ELEVATUM study ...

“At Genentech we’re challenging the status quo and pioneering a new era of inclusive research that aims to directly address long standing health disparities,” said Quita Highsmith, vice president and ...